Scientists from Oxford University and the UK Health Security Agency tracked a meningococcal B outbreak strain and found it had acquired genetic material from harmless throat bacteria through horizontal gene transfer, boosting its aggression and disease-causing potential.

The acquired genes enhanced iron uptake and altered the pilus, promoting bacterial clumping and reduced neutrophil attack, which contributed to the strain’s high transmissibility and invasiveness.

A severe Kent outbreak earlier this year was caused by this Neisseria meningitidis group B strain that gained genes from benign microbes, aiding immune evasion and growth.

Experts note the outbreak spread rapidly largely due to dense close-contact settings, especially among young people, rather than the bacteria's infectiousness alone.

Universities and other settings with heavy social mixing were crucial in accelerating transmission during the outbreak.

Current findings are preliminary and were presented as a preprint at UKHSA’s annual conference, with peer review pending.

Full results are slated for presentation at the UKHSA annual conference in Manchester.

In response, a one-off meningococcal B vaccination program was launched for students heading to university in autumn 2026, with JCVI recommending vaccination for teenagers around 15 and catch-up options.

The government initiated the autumn vaccination drive specifically for university and further education students to mitigate risk, alongside broader recommendations for routine teen vaccination.

The Kent outbreak triggered the autumn vaccine program for students and later informed JCVI’s guidance for routine teen vaccination with catch-up for those missed.

The outbreak’s traits may explain its deadly potential while also limiting sustained spread, suggesting these factors can curb transmission in asymptomatic carriers.

England’s genomic surveillance of every cultured case enabled real-time detection of the emerging invasive traits and underscored the need for ongoing sequencing and rapid response.